| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FBLG | FIBROBIOLOGICS INC | $4.46M | -785.80% | -170.70% | -234.63% | -455.90% | 0.56 | 3.61 | N/A | N/A | N/A | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $9.35M | -959.90% | -162.30% | -229.34% | 232.20% | 0.84 | 2.08 | N/A | N/A | N/A | ||
| PSTV | PLUS THERAPEUTICS INC | $27.96M | N/A | -156.00% | -468.14% | 331.30% | 3.09 | 1.23 | 100.00% | -429.40% | -360.20% | ||
| CODX | CO-DIAGNOSTICS INC | $6.70M | -125.50% | -109.60% | -228.80% | -494.30% | 0.20 | 3.87 | 64.30% | -7,533.60% | -7,793.22% | ||
| SGMO | SANGAMO THERAPEUTICS INC | $102.33M | -2,983.20% | -148.10% | -714.74% | -401.10% | -5.19 | 0.84 | 100.00% | -310.80% | -312.25% | ||
| NRXP | NRX PHARMACEUTICALS INC | $70.43M | N/A | -283.50% | 178.92% | 110.80% | -1.81 | 0.31 | 58.80% | -2,336.50% | -2,281.71% | ||
| SLE | SUPER LEAGUE ENTERPRISE INC | $3.11M | N/A | -164.10% | 1,430.62% | 529.20% | -5.34 | 0.47 | 39.60% | -137.10% | -112.29% | ||
| IMMP | IMMUTEP LTD | $51.73M | -61.80% | -50.90% | -83.72% | -144.80% | 0.49 | 2.97 | 100.00% | -777.70% | -777.30% | ||
| PDSB | PDS BIOTECHNOLOGY CORP | $33.77M | -242.00% | -90.40% | -150.13% | -264.40% | 2.30 | 2.98 | N/A | N/A | N/A | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $90.91M | -718.50% | -108.10% | -58.28% | -169.30% | 0.52 | 4.21 | 100.00% | -1,817.10% | -1,640.05% | ||
| ENLV | ENLIVEX LTD | $220.76M | 248.10% | 206.40% | 69.81% | 279.90% | 0.20 | 193.24 | N/A | N/A | N/A | ||
| OSTX | OS THERAPIES INC | $55.74M | N/A | -378.90% | 583.84% | 565.00% | -1.95 | 0.03 | N/A | N/A | N/A | ||
| GUTS | FRACTYL HEALTH INC | $72.66M | N/A | -148.10% | -136.75% | -172.70% | 11.84 | 4.78 | N/A | N/A | N/A | ||
| HELP | CYBIN INC | $239.49M | -65.60% | -55.90% | -48.03% | -428.20% | 0.06 | 13.78 | N/A | N/A | N/A | ||
| TVRD | TVARDI THERAPEUTICS INC | $29.83M | -98.90% | -47.40% | -86.61% | -106.70% | 0.53 | 2.86 | N/A | N/A | N/A | ||
| SNTI | SENTI BIOSCIENCES INC | $25.29M | -322.40% | -96.30% | -164.94% | -105.40% | 8.17 | 1.67 | 100.00% | -279,263.60% | -279,263.64% | ||
| NRSN | NEUROSENSE THERAPEUTICS LTD | $18.57M | N/A | -491.20% | 1,710.60% | 441.30% | -4.25 | 0.71 | N/A | N/A | N/A | ||
| HOVR | NEW HORIZON AIRCRAFT LTD | $62.40M | -356.80% | -202.60% | -141.57% | 2,782.60% | 0.77 | 6.51 | N/A | N/A | N/A | ||
| HUMA | HUMACYTE INC | $134.77M | -424.80% | -32.10% | -30.19% | -27.30% | 36.43 | 3.69 | -376.10% | -2,003.60% | -1,451.57% | ||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $4.61M | -217.80% | -141.50% | -208.81% | -821.20% | 0.57 | 2.66 | 35.70% | -1,252.60% | -1,172.67% | ||
| ACRV | ACRIVON THERAPEUTICS INC | $53.85M | -57.20% | -51.10% | -68.31% | -76.70% | 0.15 | 7.69 | N/A | N/A | N/A | ||
| FEMY | FEMASYS INC | $24.56M | -764.20% | -142.00% | -310.90% | -224.20% | 2.58 | 1.16 | 63.10% | -960.50% | -866.93% | ||
| CTSO | CYTOSORBENTS CORP | $35.49M | -79.90% | -17.40% | -17.37% | -11.30% | 6.49 | 2.13 | 71.50% | -22.10% | -16.15% | ||
| ACET | ADICET BIO INC | $65.35M | -83.00% | -68.00% | -68.36% | -87.70% | 0.21 | 7.47 | N/A | N/A | N/A | ||
| VNRX | VOLITIONRX LTD | $24.81M | N/A | -276.70% | 450.89% | -404.40% | -1.22 | 0.12 | 100.00% | -1,554.30% | -1,523.31% | ||
| BTAI | BIOXCEL THERAPEUTICS INC | $36.28M | N/A | -181.50% | 587.27% | -66.00% | -1.47 | 0.83 | 74.50% | -10,887.40% | -8,241.90% | ||
| NSRX | NASUS PHARMA LTD | $20.01M | N/A | -204.70% | -208.87% | 22,392.50% | 0.81 | 2.25 | N/A | N/A | N/A | ||
| INTZ | INTRUSION INC | $16.72M | -86.00% | -62.10% | -104.37% | -107.50% | 0.43 | 2.37 | 75.80% | -127.70% | -126.54% | ||
| CAN | CANAAN INC | $287.68M | -60.70% | -34.60% | -43.56% | -62.00% | 0.38 | 3.31 | 7.80% | -39.70% | -38.80% | ||
| IFRX | INFLARX NV | $64.63M | -85.10% | -65.00% | -107.93% | -133.40% | 0.33 | 4.13 | -24,677.90% | -155,582.10% | -155,410.08% | ||
| TNYA | TENAYA THERAPEUTICS INC | $150.16M | -85.20% | -70.00% | -68.90% | -153.10% | 0.19 | 6.84 | N/A | N/A | N/A | ||
| GNLX | GENELUX CORP | $108.43M | -153.30% | -111.60% | -251.09% | -203.30% | 0.65 | 2.43 | N/A | N/A | N/A | ||
| RCT | REDCLOUD HOLDINGS PLC | $31.40M | N/A | -463.60% | 655.94% | -404.50% | -2.68 | 0.27 | 52.10% | -110.30% | -108.48% | ||
| CLNN | CLENE INC | $58.07M | N/A | -119.10% | -319.39% | -89.70% | -2.03 | 0.83 | 78.50% | -13,086.50% | -11,745.50% | ||
| AVXL | ANAVEX LIFE SCIENCES CORP | $284.50M | -38.80% | -35.00% | -31.54% | 408.90% | 0.05 | 20.87 | N/A | N/A | N/A | ||
| CCCC | C4 THERAPEUTICS INC | $256.63M | -53.80% | -33.90% | -32.17% | -39.60% | 0.40 | 7.81 | 100.00% | -292.10% | -291.74% | ||
| FGNX | FG NEXUS INC | $32.59M | -53.90% | -45.50% | N/A | -46.40% | 0.14 | N/A | 100.00% | -2,839.40% | -2,763.49% | ||
| AUTL | AUTOLUS THERAPEUTICS PLC | $367.28M | -99.00% | -42.30% | -48.27% | -30.60% | 2.31 | 5.94 | -27.80% | -381.40% | -330.14% | ||
| CABA | CABALETTA BIO INC | $299.46M | -121.70% | -90.20% | -144.31% | -256.10% | 0.47 | 2.77 | N/A | N/A | N/A | ||
| MIST | MILESTONE PHARMACEUTICALS INC | $140.02M | -656.80% | -81.20% | -59.47% | -83.40% | 1.72 | 8.01 | 100.00% | -4,078.80% | -3,830.53% | ||
| PEPG | PEPGEN INC | $122.33M | -75.70% | -60.40% | -55.57% | -114.20% | 0.18 | 11.94 | N/A | N/A | N/A | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $40.48M | -158.80% | -69.70% | -167.07% | -181.70% | 1.80 | 1.62 | N/A | N/A | N/A | ||
| PALI | PALISADE BIO INC | $290.30M | -47.80% | -43.00% | -12.93% | 713.60% | 0.04 | 28.95 | N/A | N/A | N/A | ||
| BMEA | BIOMEA FUSION INC | $110.62M | -243.70% | -102.20% | -130.18% | -4,616.90% | 0.98 | 5.23 | N/A | N/A | N/A | ||
| ATOS | ATOSSA THERAPEUTICS INC | $45.30M | -65.60% | -57.70% | -88.35% | 3,160.90% | 0.21 | 5.53 | N/A | N/A | N/A | ||
| IVVD | INVIVYD INC | $367.37M | -48.70% | -34.50% | -21.63% | -414.90% | 0.15 | 7.24 | 93.00% | -98.20% | -98.25% | ||
| MNOV | MEDICINOVA INC | $67.43M | -26.30% | -24.60% | -28.69% | -411.10% | 0.10 | 8.16 | 7.60% | -2,928.80% | -2,927.32% | ||
| ALIT | ALIGHT INC | $311.62M | -119.20% | -50.00% | -80.91% | -105.60% | 3.37 | 1.31 | 33.80% | -136.90% | -132.14% |